Does GOLODIRSEN Cause Product dose omission issue? 131 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 131 reports of Product dose omission issue have been filed in association with GOLODIRSEN (Vyondys 53). This represents 32.3% of all adverse event reports for GOLODIRSEN.
131
Reports of Product dose omission issue with GOLODIRSEN
32.3%
of all GOLODIRSEN reports
0
Deaths
3
Hospitalizations
How Dangerous Is Product dose omission issue From GOLODIRSEN?
Of the 131 reports, 3 (2.3%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GOLODIRSEN. However, 131 reports have been filed with the FAERS database.
What Other Side Effects Does GOLODIRSEN Cause?
No adverse event (73)
Poor venous access (62)
Intentional dose omission (34)
Device issue (30)
Covid-19 (22)
Pyrexia (17)
Malaise (16)
Vomiting (15)
Illness (12)
Nausea (11)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which GOLODIRSEN Alternatives Have Lower Product dose omission issue Risk?
GOLODIRSEN vs GONADORELIN
GOLODIRSEN vs GONADOTROPHIN, CHORIONIC
GOLODIRSEN vs GOSERELIN
GOLODIRSEN vs GRAMICIDIN
GOLODIRSEN vs GRAMICIDIN\NEOMYCIN\POLYMYXIN B